Chemical & Healthcare Archives - Page 2 of 11

18th Aug 2021

Patent term extensions in Australia: Can a “first regulatory approval” less than 5 years after the patent filing date be ignored?

Australia’s Federal Court Decision, Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, concerns a patent claiming two pharmaceutical substances having different first regulatory approval dates;...

Australia’s Federal Court Decision, Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, concerns a patent...

4th Aug 2021

FemTech in Australia – What’s going on Down Under?

FemTech is surging around the world with new start-ups and technology entering the marketplace every day, but what’s going on Down Under? Need for FemTech As of June 2019, just over...

FemTech is surging around the world with new start-ups and technology entering the marketplace every day, but what’s going...

16th Jul 2021

Pharmaceutical patent term extension update: the Commissioner appeals the Ono decision and the Australian Patent Office releases a practice update

The Australian Patent Commissioner has appealed the Federal Court decision of Ono Pharmaceutical Co, Ltd v Commissioner of Patents FCA 643 (“Ono”) relating to pharmaceutical patent term extensions...

The Australian Patent Commissioner has appealed the Federal Court decision of Ono Pharmaceutical Co, Ltd v Commissioner of Patents...

7th Jul 2021

China update – patent linkage system in China: official implementation measures come into effect

On 4th July 2021, the Measures for Implementation of an Early Resolution Mechanism for Pharmaceutical Patent Disputes (Trial Implementation) (“Measures”) were officially published on the website of National Medical...

On 4th July 2021, the Measures for Implementation of an Early Resolution Mechanism for Pharmaceutical Patent Disputes (Trial Implementation)...

16th Jun 2021

The Australian Federal Court says “Oh No” to the Patent Office’s interpretation of the first regulatory approval for pharmaceutical patent term extensions

In Ono Pharmaceutical Co. Ltd v Commissioner of Patents FCA 643, the Federal Court has overturned the Australian Patent Office’s decision in Ono Pharmaceutical Co. Ltd et al...

In Ono Pharmaceutical Co. Ltd v Commissioner of Patents FCA 643, the Federal Court has overturned the Australian...

3rd Jun 2021

Australian patent practice note: Recent changes to examination practice for claims to crystalline polymorphs

The Australian Patent Office appears to have recently changed their examination practice regarding the support requirements for claims directed to crystalline polymorphs. Given that we have not yet seen...

The Australian Patent Office appears to have recently changed their examination practice regarding the support requirements for claims directed...

27th May 2021

Femtech: One small step for women, one giant leap for womankind

Females make up half of the population of the world, but many of the issues they have to deal with, from menstruation to menopause, have often been considered taboo...

Females make up half of the population of the world, but many of the issues they have to deal...

12th May 2021

Federal budget 2021: patent box regime announced for Australian medical and biotechnology patents

As part of Federal budget measures to foster innovation, commercialisation, and manufacturing in Australia, the Federal Government has announced yesterday the introduction of a patent box tax regime for...

As part of Federal budget measures to foster innovation, commercialisation, and manufacturing in Australia, the Federal Government has announced...

27th Jan 2021

No stretch for BOTOX – use of trade marks in marketing not an infringement

Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd FCA 1530 (14 October 2020) Allergan alleged that various references to the BOTOX trade mark, which were made...

Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd FCA 1530 (14 October 2020) Allergan alleged that...

17th Sep 2020

“Reasonableness” in withholding consent in commercialisation partnerships

University of Sydney v ObjectiVision Pty Ltd FAC 1625 It is common for commercial contracts to include provisions that prohibit a party from doing certain things unless with the...

University of Sydney v ObjectiVision Pty Ltd FAC 1625 It is common for commercial contracts to include provisions that...

19th Aug 2020

Injecting preliminary discovery into patent infringement proceedings

Sovereign Hydroseal Pty Ltd v Steynberg FCA 1084 An application for preliminary discovery of documents relating to the constituents of a ‘sealing composition’ and methods of using it to seal...

Sovereign Hydroseal Pty Ltd v Steynberg FCA 1084 An application for preliminary discovery of documents relating to the constituents of...

23rd Jun 2020

Enablement and Plausibility – is a guess good enough?

The Australian enablement requirement was introduced with the IP Laws Amendment (Raising the Bar) Act 2012 that came into effect on 15 April 2013. However, some seven years later...

The Australian enablement requirement was introduced with the IP Laws Amendment (Raising the Bar) Act 2012 that came into...